Tag: World Vaccine Congress
EBViously Announces First Details of Its EBV-001 Vaccine Candidate for the Prevention of Epstein-Barr Virus (EBV)-Induced Diseases
— Presentation at the World Vaccine Congress 2023
— EBV-infections associated with many cancers and multiple sclerosis
EBViously, a start-up developing novel vaccines based on next-generation virus-like particles, will present its approach and technology at the upcoming World Vaccine Congress 2023 (April 4-6, 2023) in Washington, DC (USA). The presentation will take place on Wednesday, April 5, 2023, at 2:55 p.m. EST in Room 201 of the Walter E. Washington Convention Center in Washington, DC.